Brief: Novabay Pharmaceuticals Announces Approval Of All Proposals At Its 2024 Annual Meeting Of Stockholders And Provides Other Corporate Updates
29/05/2024 22:24
NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS ANNOUNCES APPROVAL OF ALL
PROPOSALS AT
ITS 2024 ANNUAL MEETING OF STOCKHOLDERS AND PROVIDES OTHER
CORPORATE UPDATES
* NOVABAY PHARMACEUTICALS INC: ANNOUNCES A 1-FOR-35 REVERSE
STOCK
SPLIT
* NOVABAY PHARMACEUTICALS INC: RECEIPT OF NYSE AMERICAN
NOTICE
REGARDING STOCKHOLDERS' EQUITY
Source text for Eikon: ID:nBw9cX3NCa
Further company coverage: NBY.A
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing